26 Broadway, 14 Floor, 14 Floor
37 articles with JDRF
JDRF , the leading global type 1 diabetes (T1D) research and advocacy organization, announces the launch of the Type 1 Diabetes Index (T1D Index).
NexImmune, Inc., Yale and JDRF have begun a two-year project to explore the use of NexImmune’s AIM nanoparticles in combination with an anti-CD3 mAb to tolerize, deplete or modulate diabetes antigen-specific T cells.
Influential partners in diabetes, advocacy, and healthcare support effort to combat a nationwide insulin affordability crisis and increase accessibility.
JDRF, the leading global funder of type 1 diabetes research, proudly announces the appointment of Dr. Shareef Elnahal to the JDRF Research Committee.
Funding commitment helps remove barriers to life-saving technology for Canadians living with type 1 diabetesTD Bank Group supports JDRF's Access for All program through the TD Ready Commitment May 26, 2021
Each day, as many as 300,000 Canadians living with type 1 diabetes will make up to 300 decisions about their care.
JDRF, the leading global organization funding type 1 diabetes research, announces, in collaboration with the Harvard Stem Cell Institute, the launch of the JDRF Center of Excellence in New England.
Virtual Event JDRF Illinois One Dream Gala - Close to Home Raises Over $8.5 Million for Type 1 Diabetes Research
In a world where nonprofits have been hard hit during the pandemic, the JDRF Illinois One Dream Gala-Close to Home set a new global record for the organization when it raised more than $8.5 million on Saturday night.
-T1Detect makes T1D screening easier and more accessible with unrestricted eligibility requirements for at-home testing and financial assistance-
JDRF Canada is marking National Diabetes Awareness Month by asking those impacted to write a letter to type 1 diabetes with the launch of their "Dear Type 1" Campaign
JDRF Canada, the leading organization funding type 1 diabetes research, is marking National Diabetes Awareness Month by honouring the power and resilience of the T1D community with the “Dear Type 1” campaign.
JDRF Celebrates the Progress, Resilience and Diversity of the T1D Community with the TypeOneNation Summit
-The first-ever national diabetes education virtual symposium connected the T1D Community to discuss key issues, scientific progression and celebrate perseverance-
IQVIA™ (NYSE: IQV) today announced it is joining forces with JDRF , the leading global organization funding type 1 diabetes (T1D) research, to use non-identified patient-level, real world data and analytics to address unmet n
JDRF, the leading global organization funding type 1 diabetes (T1D) research, and Tandem Diabetes Care (NASDAQ: TNDM), a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience, announce a new national partnership to help drive awareness and education on topics related to technology innovation, diabetes management, and healthcare for peo
JDRF'S Virtual Imagine Gala One Hour/One Cause Raises Over $836,000 to Benefit Breakthrough Diabetes Research
Bebe Rexha, JoJo, RaeLynn & Ozomatli Perform in Honor of JDRF's 50th Anniversary and 50 Years of T1D Breakthroughs Hosted by KTLA's Frank Buckley
Game Over, T1D! Type 1 Diabetes Nonprofit JDRF Kicks Off Virtual Fundraising Campaign with 12-Hour Twitch Marathon on June 27
JDRF, the leading global organization funding type 1 diabetes research, will hold a 12-hour charity fundraiser on Twitch this Saturday, June 27th to bring together people who have a common interest in livestreaming as well as a common goal: to put an end to type 1 diabetes.
New virtual fundraiser unveiled in support of type 1 diabetes research On June 14th, the type 1 diabetes (T1D) community will take part in the JDRF House ParT1D for a Cure presented by Omnipod – Canada’s largest virtual house turning type one diabetes into type none. Despite the reality of physical distancing, this new, family-friendly virtual event will unite Canadians from coast to coast to get loud and raise critical funds for JDRF and its vita
NEW YORK , Feb. 20, 2020 /PRNewswire/ -- JDRF, a global leader in type 1 diabetes (T1D) research, today announced the appointment of two long-time volunteers to lead its International Board of Directors (IBOD). The two take office when the terms of current board leaders expire July 1, 2020 . JDRF's IBOD named Joseph P. Lacher, Jr. ,
Annual Report showcases year of advances, driven by $121.5 million in direct support and nearly $300 million in additional funding for T1D research
Feb. 13, 2020 15:00 UTC Over 10,000 Donors Have Now Contributed to Tidepool's Big Data Donation Project PALO ALTO, Calif.--( BUSINESS WIRE )-- Tidepool, a 501(c)3 nonprofit committed to providing free software for the diabetes community, today announced a milestone for the Tidepool Big Data Donation Project, having delivered complete, longitudinal datasets from 300 unique individuals with type 1 diabetes (T1D) to eight JDRF-awarded research teams under signed license agreemen
JDRF Recognizes NFL Superstars Who Help Drive Type 1 Diabetes Awareness Through The #MyCauseMyCleats Campaign
The NFL My Cause, My Cleats campaign, now in its fourth year, allows players to design and wear specialized cleats to express their commitment and promote the causes that are most important to them.
Lisa Wallack's contributions as a volunteer leader, both nationally and in New England, personifies invaluable commitment necessary to continue the push to find a cure for type 1 diabetes.